Drug intelligence / Profile preview

sodium monofluorophosphate + arginine

Development stage
Unknown
Lead developer
Colgate-Palmolive
Modality
Small Molecules
Administration
Topical
01

Overview

A combination oral care formulation used primarily for the treatment of dentin hypersensitivity and the prevention of dental caries. The formulation typically utilizes Pro-Argin technology, which consists of 8% arginine and calcium carbonate, alongside sodium monofluorophosphate as a fluoride source. Arginine, an amino acid, works synergistically with calcium carbonate to form a protective layer that binds to the dentin surface and occludes open dentinal tubules, thereby blocking the hydrodynamic flow that triggers sensitivity pain. Simultaneously, sodium monofluorophosphate provides fluoride ions that integrate into the tooth enamel to form fluorapatite, enhancing resistance to acid-induced demineralization and promoting remineralization of early carious lesions. The combination also supports a healthy oral microbiome by serving as a substrate for arginolytic bacteria, which produce ammonia to neutralize plaque acids.

Brand names
Colgate Sensitive Pro-ReliefElmex Sensitive ProfessionalTom's of Maine Rapid Relief
Other names
arginine and sodium monofluorophosphatePro-Argin

Beyond the preview

Go deeper on sodium monofluorophosphate + arginine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium monofluorophosphate + arginine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call